Beijing, China

Xuchao Huang

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Beijing Tuo Jie Biopharmaceutical Co. Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xuchao Huang. Retrieved from https://idiyas.com/inventor/xuchao-huang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xuchao Huang: Innovator in Biopharmaceuticals

Introduction

Xuchao Huang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative research and development efforts. His work focuses on advancing therapeutic options that can improve patient outcomes.

Latest Patents

Xuchao Huang holds a patent for a dual-agonist compound that targets both GLP-1 and GIP receptors. This patent is titled "DUAL-AGONIST COMPOUND FOR BOTH GLP-1 AND GIP RECEPTORS AND APPLICATION THEREOF." It represents a significant advancement in the treatment of metabolic disorders.

Career Highlights

Huang is currently employed at Beijing Tuo Jie Biopharmaceutical Co. Ltd., where he continues to push the boundaries of biopharmaceutical innovation. His expertise in receptor-targeted therapies has positioned him as a key player in the industry.

Collaborations

Throughout his career, Xuchao Huang has collaborated with notable colleagues, including Haiqing Hua and Ran Wu. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Xuchao Huang's contributions to biopharmaceuticals, particularly through his patent and collaborative efforts, highlight his role as an influential inventor in the field. His work continues to pave the way for innovative treatments that can benefit patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…